The global NGS sample preparation market size is expected to reach USD 9.66 billion by 2030, expanding at a CAGR of 15.4% over the forecast period according to a new report by Grand View Research, Inc. Development of companion diagnostics and personalized medicine is expected to enhance the adoption of next-generation sequencing protocols in clinical practice. NGS technology is widely applicable in theranostics domain thus leading to growth in NGS sample preparation market.
In addition, an increase in sequencing capacity and speed has led to a rise in demand for high-throughput NGS sample handling solutions. Therefore, key players are focused on the development of automated platforms for sample preparation for next-generation sequencing.
For instance, the Bravo NGS manufactured by Agilent Technologies, Inc. efficiently automates library preparation for NGS implementation and reduces the overall time of the process. A laboratory technician can use Bravo NGS to prepare whole genome libraries for nearly 1,000 samples every week. The system also reduces variability by nearly 39% as compared to other manual methods.
Request a free sample copy or view report summary: Next Generation Sequencing Sample Preparation Market Report
Oncology dominated the market and accounted for a share of 29.3% in 2023 due to multiple players engaged in the development of oncology-targeted panels
Consumables accounted for the largest market revenue share in 2023. The high share is attributed to the strong demand for consumables for commercial and research applications of NGS
Library preparation & amplification dominated the market in 2023. They assist in transforming DNA or RNA samples into libraries that have the essential adapters and indices for sequencing
Academic research accounted for the largest revenue share of 53.7% in 2023. The prevalence of next generation sequencing solutions in university and research center projects is primarily responsible for the segment's dominance
North America dominated the global market in 2023 with a revenue share of 41.5%. Factors contributing to the growth include the increasing demand for diagnostic tools, public awareness
Grand View Research has segmented the NGS sample preparation market on the basis of product & service workflow, application, end-use, and region:
NGS Sample Preparation Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Consumables
Services
NGS Sample Preparation Workflow Outlook (Revenue, USD Million, 2018 - 2030)
Nucleic Acid Extraction
Library Preparation & Amplification
Target Enrichment
Library Quantification/QC
NGS Sample Preparation Application Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Clinical Investigation
Reproductive Health
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
NGS Sample Preparation End Use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other
NGS Sample Preparation Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
List Of Key Players in the NGS Sample Preparation Market
Illumina, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
QIAGEN
PerkinElmer Inc.
F. Hoffmann-La Roche Ltd
BGI Genomics
Danaher Corporation (Beckman Coulter)
Eurofins Scientific
"The quality of research they have done for us has been excellent..."